» Articles » PMID: 29580147

Early Brain Metastasis of Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy Followed by Surgery: A Case Report and Literature Review

Overview
Specialties Oncology
Pharmacology
Date 2018 Mar 28
PMID 29580147
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy and surgery followed by early brain metastasis is rare. A 52-y-old male patient who was diagnosed with advanced gastric cancer (cT4N2M0, stage ШB). Radiological examinations after three cycles of preoperative chemotherapy with a modified FOLFOX6 (mFOLFOX6) regimen showed a partial response (PR) had been achieved. The patient underwent curative surgery consisting of proximal gastrectomy, and D2 lymph node dissection. The lack of abnormal gastric cancer cells in the primary lesion or lymph nodes confirmed a pathological complete response (pCR). Postoperative chemotherapy with oral S-1 was administrated. However, during the second cycles of postoperative chemotherapy, the patient experienced headaches, projectile vomiting and convulsion. Upon further examination, a tumor representing metastasis to the brain was recognized by cranial enhanced magnetic resonance imaging (MRI) examination and cytopathology of cerebrospinal fluid. In addition to documenting the case report, we reviewed the literature associated to features of metastatic brain malignancies that form from gastric cancer. In short, advanced gastric cancer patents achieved pCR after preoperative chemotherapy typically have good prognosis; however, great attention should be paid on detecting metastatic events.

Citing Articles

Survival and Treatment Outcomes in Gastric Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis.

Sur D, Turcu-Stiolica A, Moraru E, Lungulescu C, Lungulescu C, Iovanescu V Cancers (Basel). 2024; 16(22).

PMID: 39594751 PMC: 11593042. DOI: 10.3390/cancers16223796.


The Role of Neoadjuvant Therapy in a Giant Gastric Gastrointestinal Stromal Tumour: A Case Report and Review of the Literature.

Alsaud J, Alruqayi S, Alomair A Cureus. 2024; 16(3):e55655.

PMID: 38586745 PMC: 10996978. DOI: 10.7759/cureus.55655.


Brain metastasis from gastric adenocarcinoma: A large comprehensive population-based cohort study on risk factors and prognosis.

Huang L, Wang L, Shi Y, Zhao Y, Xu C, Zhang J Front Oncol. 2022; 12:897681.

PMID: 36338733 PMC: 9635449. DOI: 10.3389/fonc.2022.897681.

References
1.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

2.
He H, Wang Y, Le Y, Duan K, Yan X, Liao Q . Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci Ther. 2012; 18(12):994-1002. PMC: 6493557. DOI: 10.1111/cns.12018. View

3.
Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y . Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Ann Surg Oncol. 2014; 21 Suppl 3:S385-9. DOI: 10.1245/s10434-014-3615-8. View

4.
Wang Y, Yu Y, Li W, Feng Y, Hou J, Ji Y . A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014; 73(6):1155-61. PMC: 4032640. DOI: 10.1007/s00280-014-2449-1. View

5.
Zhang J, Chen R, Zhang J, Cai J, Meng H, Wu G . Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer. Chin Med J (Engl). 2012; 125(12):2144-50. View